XML 58 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Parent Company Financial Information (Tables)
 12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
Schedule of condensed balance sheets
           
     
   December 31, 
(dollars in thousands)   2023    2022 
Assets          
Cash and cash equivalents  $9,408    13,882 
Investment in subsidiaries   339,516    317,102 
Other assets   146    21 
Total assets  $349,070    331,005 
Liabilities and Shareholders’ Equity          
Accrued expenses  $281    279 
Subordinated debentures   36,322    36,214 
Shareholders’ equity   312,467    294,512 
Total liabilities and shareholders’ equity   $349,070    331,005 
Schedule of condensed statements of income
                 
     
   For the years ended December 31, 
(dollars in thousands)   2023    2022    2021 
Revenues               
Interest income  $15    20    17 
Total revenue   15    20    17 
Expenses               
Interest expense   2,197    1,730    1,523 
Other expenses   249    240    285 
Total expenses   2,446    1,970    1,808 
Income tax benefit   511    409    376 
Loss before equity in undistributed net income of subsidiaries   (1,920)   (1,541)   (1,415)
Equity in undistributed net income of subsidiaries    15,346    30,656    48,126 
Net income  $13,426    29,115    46,711 
Schedule of condensed statements of cash flows
                 
     
   For the years ended December 31, 
(dollars in thousands)   2023    2022    2021 
Operating activities               
Net income  $13,426    29,115    46,711 
Adjustments to reconcile net income to cash provided by operating activities               
Equity in undistributed net income of subsidiaries    (15,346)   (30,656)   (48,126)
Compensation expense related to stock options and restricted stock grants   1,943    2,026    1,647 
(Increase) decrease in other assets    (125)   -    8 
Increase in accrued expenses and subordinated debentures   110    113    108 
 Net cash provided by operating activities    8    598    348 
Investing activities               
Investment in subsidiaries, net    (5,000)   -    - 
 Net cash used for investing activities    (5,000)   -    - 
Financing activities               
Issuance of common stock    -    -    - 
Proceeds from the exercise of stock options and warrants   518    905    3,012 
 Net cash provided by financing activities    518    905    3,012 
 Net increase (decrease) in cash and cash equivalents    (4,474)   1,503    3,360 
Cash and cash equivalents, beginning of year    13,882    12,379    9,019 
Cash and cash equivalents, end of year   $9,408    13,882    12,379